Skip to content

Screening of Biomarkers for Postoperative Cognitive Dysfunction in Patients with Metabolic Syndrome

Screening of Biomarkers for Postoperative Cognitive Dysfunction in Patients with Metabolic Syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600121575
Enrollment
Unknown
Registered
2026-04-01
Start date
2026-04-01
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Cognitive Dysfunction

Interventions

Observation group:None

Sponsors

The First Hospital of Lanzhou University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients in the metabolic syndrome group must meet at least three of the indicators identified in the MetS diagnostic criteria established by the Chinese Diabetes Society (CDS) in 2020: (1) Abdominal obesity (i.e., central obesity): waist circumference >90 cm for men, >85 cm for women; (2) Fasting blood glucose >6.1 mmol/L, and/or 2-hour plasma glucose >7.8 mmol/L, and/or diagnosed diabetes under treatment; (3) Blood pressure >130/85 mmHg, and/or diagnosed hypertension under treatment; (4) Fasting triglycerides >1.7 mmol/L; (5) Fasting HDL-C =40 years; 4. Patients scheduled for gastrointestinal tumor resection under general anesthesia; 5. Participants whose mother tongue is Chinese, with good audiovisual comprehension, able to cooperate to complete neuropsychological tests; 6. Voluntarily participating in this study and signing the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Past neurological history: History of cerebrovascular disease, epilepsy, Parkinson's disease, or other central nervous system degenerative diseases; major cardiovascular or cerebrovascular adverse events occurring recently (within 6 months); 2. Psychiatric and medication history: History of psychiatric disorders, or previous long-term use of psychiatric medications; 3. Preoperative cognitive dysfunction: Cognitive dysfunction assessed preoperatively by the Mini-Mental State Examination (MMSE) (illiterate <=17 points, primary school education <=20 points, secondary school or above education <=24 points); 4. Metabolic interfering factors: Presence of thyroid dysfunction, acute gout attacks, or autoimmune diseases; 5. Poor compliance: Severe communication barriers (such as severe hearing or vision impairment, aphasia, etc.) preventing completion of neurocognitive assessment scales.

Design outcomes

Primary

MeasureTime frame
Postoperative Cognitive Dysfunction;

Secondary

MeasureTime frame
Extubation time;Length of stay in the PACU;Postoperative length of hospital stay;Overall incidence of postoperative complications;Recovery of gastrointestinal function;Unplanned ICU admission rate;Time to emergence;

Countries

China

Contacts

Public ContactYatao Liu

The First Hospital of Lanzhou University

liuyt@lzu.edu.cn+86 181 5210 7860

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 17, 2026